Rudra Shares and Stock Brokers Ltd Broker Research reports

One of India's fastest growing hospitality brands An asset-light business model, adequately capitalized balance sheet, robust cash flows, exciting growth prospects & capable management inspire confidence in its prospects over the next two years. As on September 2016, company has 797 rooms with 11 properties out of which 2 owned & 9 leased. This...

Leading automotive and industrial lubricant manufacturing company in India Castrol's strong brand position & superior distribution network allows it to command higher pricing power and premium for its products over its competitors in spite of decline in base oil prices. Castrol, which is the price maker in the Indian automotive lubricant market, will maintain stable realizations, going forward. With revival in industrial lubricants business in half-year ended June 2016, industrial...

With a Portfolio of more than 2,000 products across the world, presence in more than 150 countries across branded and generic markets, 47 manufacturing sites, multiple facilities approved by various regulatory authorities across the world including USFDA, company is ranked Number 1 Pharma company in India, 5 th in US with one of the largest ANDAs pipeline (159 ANDAs awaiting approval) & Largest Indian...

Biocon is one of the largest insulin's producer in Asia and its rh-Insulin today, has marketing approvals in 60 countries & over 20 countries for Insulin Glargine. As on 25th Aug. 2016, European Medicines Agency (EMA) has accepted to review Mylan and Biocon's application for a biosimilar called Trastuzumab, used for certain breast and gastric cancers. Marketing approval for the drug is likely to come in next 12-18 months having an addressable market close to USD 7 billion, which opens up a huge opportunity for Biocon and Mylan both. This is the second biosimilar submission developed by partnership that has been accepted for review in Europe. Last month, Mylan's...

Second largest pump manufacturer in India with 15% market share having an planned capex of ` 250 crores in next three years Company expects the market for pumps and services to grow moderately & market for valves is expected to be sluggish, primarily due to poor demand from the power sector. Whereas, company has taken effective steps to improve operational efficiency to maintain the earnings. As a part of its growth strategy, company plans to expand its operations over the next five years. KSB will set up a new plant for manufacturing high-end engineered pumps for super critical thermal power plants at an estimated capex of around ` 250 Crores to be financed partially from internal generations and...

Having emerged resiliently from the AP crisis and now armed with a diversified regional presence, sizeable scale , Bharat Financial Inclusion delivered robust growth in FY 16 Company has reduced the interest rate charged to borrowers from 20.75% to 19.75% on income generating loans extended on or after 07 December 2015. With this reduction, Bharat financial charges the lowest interest rate among private MFIs in the world. During FY16, company witnessed robust growth in disbursements, which grew 75% over the last year to ` 12088 crores, while Gross Loan Portfolio grew 84% Y-O-Y to `7677 crores. Company also had robust growth in Net Interest Income, which grew by 69% over the last year....

Company diversified its existing product portfolio from refrigerators & washing machines to air conditioners, microwave oven, built-in appliances, induction cook top & water purifiers. Company is expecting double-digit profitable growth in future, while continuing to focus on expanding its product portfolio and footprints in terms of numeric reach and in-store execution as well as driving manufacturing efficiencies. Now, company is looking to ramp up its footprint and portfolio in built-in appliances segment with Kitchen aid apart from its biggest businesses i.e. refrigerators and washing machines....